Data listing
Top hard-to-find medications
Direct summary
Sample list of medications from Rare Medication directory for B2B readers. Not a clinical priority list. Availability depends on market conditions and regulations.
This list surfaces published directory entries for procurement readers exploring hard-to-find medicines. It is informational and updates as content expands.
Medications (30)
- Glycoprotein IIb/IIIa inhibitor used in selected hospital cardiology pathways per label and protocol.
- Branded verteporfin product used in clinician-directed ophthalmic treatment workflows.
- Branded peginterferon product used in specialty programs where local authorization and labeling apply.
- Potent opioid used in anesthesia workflows where institutional protocols and controls apply.
- Ultra short-acting opioid used in anesthesia and monitored settings with strict handling rules.
- Injectable medicine used in selected acute care scenarios per institutional protocol and labeling.
- Injectable opioid used in inpatient analgesia pathways where institutional policies govern use.
- Injectable opioid analgesic used in controlled hospital workflows with strict custody and protocol requirements.
- Antineoplastic used in selected hematologic malignancies under specialist supervision.
- Short-acting bronchodilator used in acute bronchospasm management per clinical pathways.
- Sedative used in ICU and procedural sedation settings under monitoring protocols.
- Local anesthetic used in surgical and obstetric anesthesia workflows per institutional protocol.
- Anticholinergic medicine used in resuscitation and perioperative pathways where protocols define dosing.
- Third-generation cephalosporin antibiotic used in inpatient settings per local guidelines.
- Antibiotic used in selected infections when hospital protocols and susceptibility data support use.
- Corticosteroid injection used in acute care settings according to clinical indication and protocol.
- Platinum chemotherapy used in multiple infusion regimens managed by oncology teams.
- Insulin therapy used in diabetes care where product presentation and device compatibility matter.
- Long-acting injectable antipsychotic used in programs where administration and monitoring follow strict protocols.
- Vitamin B12-related injectable therapy used in specific clinical scenarios per local labeling.
- Photosensitizer used in some ophthalmic treatment workflows where clinician-directed protocols apply.
- Topoisomerase inhibitor used in certain oncology regimens according to label and protocol.
- Antineoplastic used in selected hematologic oncology pathways under specialist supervision.
- Pegylated interferon used in specialty programs where local labeling defines eligible patient populations.
- Bronchodilator used in asthma and acute bronchospasm management under appropriate clinical pathways.
- Widely used antibiotic prescribed according to local guidelines and susceptibility considerations.
- Antimetabolite used in oncology care, including infusion protocols managed by specialist teams.
- Taxane chemotherapy used in multiple cancer types as part of hospital-managed infusion programs.
- Antimetabolite therapy used in oncology and, in other settings, under distinct protocols and monitoring.
- Platinum-based chemotherapy used in several solid tumor regimens under specialist supervision.